Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

2.450 -0.230 (-8.58%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Voyager Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge ↗

February 29, 2024

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.

Via Benzinga

Topics Economy Stocks

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket ↗

February 29, 2024

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Via Benzinga

Voyager Therapeutics: Q4 Earnings Insights ↗

February 28, 2024

Via Benzinga

Earnings Preview For Voyager Therapeutics ↗

February 27, 2024

Via Benzinga

Voyager Therapeutics Inc. (NASDAQ: VYGR) Near the Top of Equities by Percentage Gain on 1/3

January 03, 2024

Via Investor Brand Network

Voyager Therapeutics Inc. (NASDAQ: VYGR) Near the Top of Equities by Percentage Gain on 1/2

January 02, 2024

Via Investor Brand Network

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 28, 2024

Via Benzinga

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff ↗

February 26, 2024

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

Via InvestorPlace

5 Value Stocks To Watch In The Healthcare Sector ↗

February 05, 2024

Via Benzinga

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024 ↗

January 11, 2024

The 2024 investment trends are slowly making themselves known. Make sure you follow our guide to stay ahead of the curb.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

January 08, 2024

Via Benzinga

Voyager Therapeutics stock pops 30% on deal with Novartis

January 08, 2024

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took

Via MarketBeat

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 05, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.

Via Benzinga

Topics Stocks

Voyager Therapeutics Stock Tanked After-Hours - Here's Why ↗

January 04, 2024

Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares are trading lower in Thursday's after-hours session after announcing a proposed public offering

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 03, 2024

Via Benzinga

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Crude Oil Down 2%; Tesla Deliveries Top Estimates ↗

January 02, 2024

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...

Via Benzinga

Topics Stocks

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Dow Turns Higher; Anavex Life Sciences Shares Plunge ↗

January 02, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...

Via Benzinga

Topics Stocks

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today ↗

January 02, 2024

VYGR stock is in focus as analysts expect more pharma deals in 2024, although some think these deals will be sunk by the Biden administration.

Via InvestorPlace

Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today? ↗

January 02, 2024

Voyager Therapeutics Inc (NASDAQ: VYGR) announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG (NYSE: NVS), to advance pot

Via Benzinga

Novartis Sweetens Its Deal With Voyager, And Voyager Stock — Up 25% — Flashes A Bullish Sign ↗

January 02, 2024

The company inked an expanded collaboration deal with Novartis to test out gene therapies.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.